Hypertrophic cardiomyopathy: Difference between revisions
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnostic Study of Choice| [[Hypertrophic cardiomyopathy symptoms|History and Symptoms]] | [[Hypertrophic cardiomyopathy physical examination|Physical examination]] | Laboratory findings | [[Hypertrophic cardiomyopathy electrocardiogram|Electrocardiogram]] | X Ray | Echocardiography and Ultrasound | [[Hypertrophic cardiomyopathy CT|CT]] | [[Hypertrophic cardiomyopathy diagnostic study of choice|Diagnostic Study of Choice]]| [[Hypertrophic cardiomyopathy symptoms|History and Symptoms]] | [[Hypertrophic cardiomyopathy physical examination|Physical examination]] | [[Hypertrophic cardiomyopathy laboratory findings|Laboratory findings]] | [[Hypertrophic cardiomyopathy electrocardiogram|Electrocardiogram]] | [[Hypertrophic cardiomyopathy x ray|X Ray]] | [[Hypertrophic cardiomyopathy echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Hypertrophic cardiomyopathy CT scan|CT Scan]] | [[Hypertrophic cardiomyopathy MRI|MRI]] |[[Hypertrophic cardiomyopathy other imaging findings|Other Imaging Findings]] | [[Hypertrophic cardiomyopathy other diagnostic studies|Other Diagnostic Studies]]. | ||
==Treatment== | ==Treatment== |
Revision as of 15:15, 10 March 2020
For patient information click here
Hypertrophic cardiomyopathy | |
Hypertrophic cardiomyopathy. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Hypertrophic Cardiomyopathy Microchapters |
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hypertrophic cardiomyopathy On the Web |
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
Risk calculators and risk factors for Hypertrophic cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Synonyms and keywords: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent)
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Hypertrophic Cardiomyopathy from Other Diseases
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice| History and Symptoms | Physical examination | Laboratory findings | Electrocardiogram | X Ray | Echocardiography and Ultrasound | CT Scan | MRI |Other Imaging Findings | Other Diagnostic Studies.
Treatment
- Medical therapy, Interventions, Surgery, Primary Prevention, Secondary Prevention, Cost Effectiveness of Therapy, Future or Investigational Therapy